Feltl & Co Upgrades Biocept (BIOC) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Biocept (BIOC) Reports Q3 Loss of $0.57/Share
November 9, 2016 4:36 PM ESTBiocept (NASDAQ: BIOC) reported Q3 EPS of ($0.57), versus ($0.72) reported last year. Revenue for the quarter came in at $1.05 million, versus $165 thousand reported last year.
For earnings history and earnings-related data on Biocept (BIOC) click here.
... More